Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment
Coronavirus disease 2019 (COVID-19) is a global pandemic increasingly encountered in the clinical setting. It typically manifests as a respiratory illness, although cardiac involvement is common and portends a worse prognosis. We present the case of a 56-year-old male admitted with COVID-19 fulminant myocarditis and cardiogenic shock. We discuss important aspects of the multidisciplinary and interventional care involved in treating cardiogenic shock as well as the likely mechanisms of, and potential treatment for, COVID-19 myocarditis. The various pathways of myocardial injury, including direct viral damage, macrophage activation, and lymphocytic infiltration, are outlined in detail in addition to associated pathology such as cytokine release syndrome. COVID-19 is a complex and multisystem disease process; in addition to supportive care, specific consideration should be given to the underlying mechanism of injury for each patient.
original_citation: Gay HC, Sinha A, Michel E, Mozer AB, Budd A, Feinstein MJ, Benzuly KH, Al-Qamari A, Pawale AA, Vorovich EE. Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment. Esc Heart Failure. 2020;7(6):4367-4370.
ESC Heart Failure - 2020 - Gay - Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial.pdfmd5:c3d22039852888b8466832b52af03086
|4.6 MB||Preview Download|
2020-12When the item was originally created.